On the basis of data obtained from targeted amplicon sequencing and PCR amplicon sequencing using genomic DNA, there were no relapsed tumor–specific mutations in the splicing junction and intronic region in PD-L1, suggesting that these PD-L1 variants resulted from aberrant splicing. Here, CD274 is linked to neoplasm.